Results 131 to 140 of about 63,846 (238)
Climate Change and Food Security: A Framework for Agenda Setting and Policy Analysis in Iran. [PDF]
Allipour Birgani R +4 more
europepmc +1 more source
A genome‐wide microRNA CRISPR screen identifies miR‐18a as a master regulator of cross‐resistance in melanoma. Loss of miR‐18a activates the AJUBA–YAP/Hippo axis to confer BRAFi resistance and enhances THBS1–CD47 interaction to impair CD8+ T cell immunity. hnRNP A1 is identified as an upstream regulator of miR‐18a processing.
Zhao Wang +19 more
wiley +1 more source
Universal health coverage in Lebanon: agenda setting using Kingdon's model and a proposed legal framework for revenue allocation. [PDF]
Mouawad J, Lteif MR, Mina W, Karam R.
europepmc +1 more source
An agenda-setting paper on data sharing platforms: euCanSHare workshop. [PDF]
Devriendt T +20 more
europepmc +1 more source
PET Imaging of Cardiac Inflammation in Viral Myocarditis Using a DPP4‐Targeted Probe
This study describes a DPP4‐targeted PET probe for imaging myocardial inflammation by selectively targeting activated immune cells. Derived from the clinically approved small‐molecule inhibitor linagliptin, the probe demonstrates favorable biodistribution with specific cardiac uptake in myocarditis.
Wanhao Gao +14 more
wiley +1 more source
Agenda-setting in the clinical encounter: A systematic review protocol. [PDF]
Sierpe A +5 more
europepmc +1 more source
Research agenda setting with children with juvenile idiopathic arthritis: Lessons learned. [PDF]
Aussems K +5 more
europepmc +1 more source
AUTACE is a bifunctional nanoplatform that integrates tumor targeting, immune engagement, and on‐demand KRAS degradation. It targets KRAS/TP53 co‐mutant tumors via TP53‐specific TCRs, elicits antitumor CD8+ T‐cell responses through surface anti‐CD3 antibodies, and uses low‐intensity focused ultrasound (LIFU) to trigger controlled release of the KRAS ...
Luo Li +6 more
wiley +1 more source
Media representation of tobacco control in China: A comparative analysis of agenda-setting across different policy contexts during 2017-2022. [PDF]
Chen Y +7 more
europepmc +1 more source
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey +6 more
wiley +1 more source

